BEYOND AIR INC. - COMMON STOCK

Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

10 фев 2025 16:05:00 Источник Nasdaq GlobeNewswire

Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

05 фев 2025 09:29:17 Источник Nasdaq GlobeNewswire

Beyond Air® Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast

27 янв 2025 16:05:00 Источник Nasdaq GlobeNewswire

Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia

24 янв 2025 09:15:00 Источник Nasdaq GlobeNewswire

Beyond Air to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

06 янв 2025 08:00:00 Источник Nasdaq GlobeNewswire

Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy

03 дек 2024 16:05:00 Источник Nasdaq GlobeNewswire

Beyond Air Receives CE Mark in Europe for the LungFit® PH System

02 дек 2024 07:30:00 Источник Nasdaq GlobeNewswire

NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board

26 ноя 2024 07:30:00 Источник Nasdaq GlobeNewswire

Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference

14 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire

Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update

11 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire

Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

11 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire

Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast

29 окт 2024 16:22:08 Источник Nasdaq GlobeNewswire

Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

07 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire

Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks

02 окт 2024 07:30:00 Источник Nasdaq GlobeNewswire

Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed

27 сен 2024 07:34:00 Источник Nasdaq GlobeNewswire

Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital

27 сен 2024 07:32:00 Источник Nasdaq GlobeNewswire

Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

27 сен 2024 07:30:00 Источник Nasdaq GlobeNewswire

Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

23 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire

Beyond Air® Reports Fiscal First Quarter 2025 Financial Results and Provides Corporate Update

06 авг 2024 16:05:01 Источник Nasdaq GlobeNewswire

Beyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia

31 июл 2024 16:15:00 Источник Nasdaq GlobeNewswire